Literature DB >> 19796499

Who's in favor of translational cell therapy for stroke: STEPS forward please?

Michael Chopp1, Gary K Steinberg, Douglas Kondziolka, Mei Lu, Tonya M Bliss, Yi Li, David C Hess, Cesario V Borlongan.   

Abstract

A consortium of translational stem cell and stroke experts from multiple academic institutes and biotechnology companies, under the guidance of the government (FDA/NIH), is missing. Here, we build a case for the establishment of this consortium if cell therapy for stroke is to advance from the laboratory to the clinic.

Entities:  

Mesh：

Year:  2009        PMID： 19796499      PMCID： PMC3962837          DOI： 10.3727/096368909X470883

Source DB:  PubMed          Journal:  Cell Transplant        ISSN： 0963-6897            Impact factor:   4.064


  6 in total

1.  Transplantation of hNT neurons into the ischemic cortex: cell survival and effect on sensorimotor behavior.

Authors:  T M Bliss; S Kelly; A K Shah; W C Foo; P Kohli; C Stokes; G H Sun; M Ma; J Masel; S R Kleppner; T Schallert; T Palmer; G K Steinberg
Journal:  J Neurosci Res       Date:  2006-05-01       Impact factor: 4.164

2.  Homologous species restriction in lysis of erythrocytes by terminal complement proteins.

Authors:  G M Hänsch; C H Hammer; P Vanguri; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

3.  Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats.

Authors:  C V Borlongan; Y Tajima; J Q Trojanowski; V M Lee; P R Sanberg
Journal:  Exp Neurol       Date:  1998-02       Impact factor: 5.330

4.  Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats.

Authors:  J Chen; Y Li; L Wang; Z Zhang; D Lu; M Lu; M Chopp
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

5.  Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke.

Authors:  Cesar V Borlongan; Martin Hadman; Cyndy Davis Sanberg; Paul R Sanberg
Journal:  Stroke       Date:  2004-09-02       Impact factor: 7.914

6.  Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex.

Authors:  X Wang; A L Siren; Y Liu; T L Yue; F C Barone; G Z Feuerstein
Journal:  Brain Res Mol Brain Res       Date:  1994-10
  6 in total
  25 in total

Review 1.  Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!

Authors:  C V Borlongan
Journal:  Leukemia       Date:  2011-07-05       Impact factor: 11.528

2.  Long-term survival and serial assessment of stroke damage and recovery - practical and methodological considerations.

Authors:  Michel Modo
Journal:  J Exp Stroke Transl Med       Date:  2009-01

3.  The brain and eye: Treating cerebral and retinal ischemia through mitochondrial transfer.

Authors:  Matt Heyck; Brooke Bonsack; Henry Zhang; Nadia Sadanandan; Blaise Cozene; Chase Kingsbury; Jea-Young Lee; Cesar V Borlongan
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-11

Review 4.  Baby STEPS: a giant leap for cell therapy in neonatal brain injury.

Authors:  Cesar V Borlongan; Michael D Weiss
Journal:  Pediatr Res       Date:  2011-07       Impact factor: 3.756

Review 5.  The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders.

Authors:  Cesar V Borlongan; Loren E Glover; Naoki Tajiri; Yuji Kaneko; Thomas B Freeman
Journal:  Prog Neurobiol       Date:  2011-08-30       Impact factor: 11.685

Review 6.  One, two, three steps toward cell therapy for stroke.

Authors:  Theo Diamandis; Cesar V Borlongan
Journal:  Stroke       Date:  2014-12-11       Impact factor: 7.914

Review 7.  Stem cell therapy in intracerebral hemorrhage rat model.

Authors:  Marcos F Cordeiro; Ana P Horn
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 8.  In vivo animal stroke models: a rationale for rodent and non-human primate models.

Authors:  Naoki Tajiri; Travis Dailey; Christopher Metcalf; Yusef I Mosley; Tsz Lau; Meaghan Staples; Harry van Loveren; Seung U Kim; Tetsumori Yamashima; Takao Yasuhara; Isao Date; Yuji Kaneko; Cesario V Borlongan
Journal:  Transl Stroke Res       Date:  2013-06       Impact factor: 6.829

9.  ADVANCES IN THE CELL-BASED TREATMENT OF NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY.

Authors:  Mibel M Pabon; Cesar V Borlongan
Journal:  Future Neurol       Date:  2013-03-01

Review 10.  Advancing critical care medicine with stem cell therapy and hypothermia for cerebral palsy.

Authors:  Travis Dailey; Yusef Mosley; Mibel Pabon; Sandra Acosta; Naoki Tajiri; Harry van Loveren; Yuji Kaneko; Cesar V Borlongan
Journal:  Neuroreport       Date:  2013-12-18       Impact factor: 1.837
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.